Skip to content

Pulse Biosciences, Inc. PLSE Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

AtriCure logo
AtriCureATRC
Merit Medical Systems logo
Merit Medical SystemsMMSI
LivaNova logo
LivaNovaLIVN

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s capital investments accrued but not yet paid?
Pulse Biosciences, Inc. (PLSE) reported capital investments accrued but not yet paid of $28K in Q1 2026.
How has Pulse Biosciences, Inc.'s capital investments accrued but not yet paid changed year-over-year?
Pulse Biosciences, Inc.'s capital investments accrued but not yet paid increased by 7.7% year-over-year, from $26K to $28K.